224 related articles for article (PubMed ID: 31233404)
1. Observational Study Examining the Diagnostic Practice of Ki67 Staining for Melanocytic Lesions.
Vyas NS; Charifa A; Desman GT; Goldberg M; Singh R; Phelps RG; McNiff JM
Am J Dermatopathol; 2019 Jul; 41(7):488-491. PubMed ID: 31233404
[TBL] [Abstract][Full Text] [Related]
2. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
Garola R; Singh V
Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical double stains against Ki67/MART1 and HMB45/MITF: promising diagnostic tools in melanocytic lesions.
Nielsen PS; Riber-Hansen R; Steiniche T
Am J Dermatopathol; 2011 Jun; 33(4):361-70. PubMed ID: 21610457
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
5. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
[TBL] [Abstract][Full Text] [Related]
6. Another point of view on p16 and Ki67 expression in melanocytic and non-melanocytic cutaneous lesions.
Donati P; Paolino G; Panetta C; Cota C; Zaccarini M; Muscardin L
Acta Dermatovenerol Croat; 2013; 21(3):149-54. PubMed ID: 24183217
[TBL] [Abstract][Full Text] [Related]
7. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases.
Harvell JD; Bastian BC; LeBoit PE
Am J Surg Pathol; 2002 May; 26(5):654-61. PubMed ID: 11979096
[TBL] [Abstract][Full Text] [Related]
8. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
9. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.
Kapur P; Selim MA; Roy LC; Yegappan M; Weinberg AG; Hoang MP
Mod Pathol; 2005 Feb; 18(2):197-204. PubMed ID: 15467715
[TBL] [Abstract][Full Text] [Related]
10. Nestin Expression in Spitzoid Lesions: An Immunohistochemical Characterization With Clinical and Dermoscopic Correlations.
Guanziroli E; Del Gobbo A; Coggi A; Venegoni L; Fanoni D; Ercoli G; Boggio F; Veraldi S; Cavicchini S; Berti E; Ferrero S; Gianotti R
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):430-435. PubMed ID: 30212379
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
[TBL] [Abstract][Full Text] [Related]
12. Atypical melanocytic lesions: a historical overview.
Manchi M; Canzonieri V
Pol J Pathol; 2019; 70(1):26-32. PubMed ID: 31556548
[TBL] [Abstract][Full Text] [Related]
13. Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.
Puri PK; Valdes CL; Burchette JL; Grichnik JM; Turner JW; Selim MA
J Cutan Pathol; 2010 Sep; 37(9):1010-2. PubMed ID: 20002650
[No Abstract] [Full Text] [Related]
14. Expression of c-kit (CD117) in Spitz nevus and malignant melanoma.
Isabel Zhu Y; Fitzpatrick JE
J Cutan Pathol; 2006 Jan; 33(1):33-7. PubMed ID: 16441409
[TBL] [Abstract][Full Text] [Related]
15. Automated quantification of Ki67/MART1 stains may prevent false-negative melanoma diagnoses.
Wandler A; Spaun E; Steiniche T; Nielsen PS
J Cutan Pathol; 2016 Nov; 43(11):956-962. PubMed ID: 27461337
[TBL] [Abstract][Full Text] [Related]
16. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.
Barnhill RL; Argenyi ZB; From L; Glass LF; Maize JC; Mihm MC; Rabkin MS; Ronan SG; White WL; Piepkorn M
Hum Pathol; 1999 May; 30(5):513-20. PubMed ID: 10333219
[TBL] [Abstract][Full Text] [Related]
17. [Spitz nevus and Reed nevus: simulating melanoma in adults].
Paredes B; Hardmeier T
Pathologe; 1998 Nov; 19(6):403-11. PubMed ID: 9885003
[TBL] [Abstract][Full Text] [Related]
18. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
19. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions.
Li LX; Crotty KA; McCarthy SW; Palmer AA; Kril JJ
Am J Dermatopathol; 2000 Dec; 22(6):489-95. PubMed ID: 11190439
[TBL] [Abstract][Full Text] [Related]
20. Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children.
Tom WL; Hsu JW; Eichenfield LF; Friedlander SF
J Am Acad Dermatol; 2011 Mar; 64(3):559-72. PubMed ID: 21255872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]